We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Eastman Chemical
EMN
$7.69B
| $21.6M | 0.05% |
267,677
+9,870
| +4% | +$776K |
|
377
Whirlpool
WHR
$2.49B
| $21.6M | 0.05% |
126,096
+4,890
| +4% | +$868K |
|
378
DaVita
DVA
$15.5B
| $21.5M | 0.05% |
316,466
+457
| +0.1% | +$30.3K |
|
|
XEC
379
DELISTED
CIMAREX ENERGY CO
XEC
| $21.5M | 0.05% |
179,672
+6,230
| +4% | +$808K |
|
380
CarMax
KMX
$8.39B
| $21.4M | 0.05% |
361,841
+7,659
| +2% | +$498K |
|
381
T-Mobile US
TMUS
$195B
| $21.3M | 0.05% |
330,237
-14,471
| -4% | -$890K |
|
|
CA
382
DELISTED
CA, Inc.
CA
| $21.2M | 0.05% |
669,834
+22,253
| +3% | +$716K |
|
383
D.R. Horton
DHI
$41.2B
| $21M | 0.05% |
629,748
+18,079
| +3% | +$561K |
|
384
Extra Space Storage
EXR
$32.3B
| $20.9M | 0.05% |
280,684
+18,553
| +7% | +$1.4M |
|
385
Packaging Corp of America
PKG
$22.2B
| $20.7M | 0.05% |
226,419
-15,072
| -6% | -$1.38M |
|
386
Advance Auto Parts
AAP
$3.53B
| $20.7M | 0.05% |
139,869
+3,264
| +2% | +$525K |
|
|
XL
387
DELISTED
XL Group Ltd.
XL
| $20.7M | 0.05% |
519,403
+8,838
| +2% | +$347K |
|
388
Harley-Davidson
HOG
$2.61B
| $20.6M | 0.05% |
340,135
+7,195
| +2% | +$423K |
|
389
EQT Corp
EQT
$32.9B
| $20.6M | 0.05% |
618,645
+29,633
| +5% | +$989K |
|
|
ANDV
390
DELISTED
Andeavor
ANDV
| $20.6M | 0.05% |
253,670
+41,074
| +19% | +$3.44M |
|
391
Alaska Air
ALK
$5.11B
| $20.5M | 0.05% |
222,293
+8,569
| +4% | +$811K |
|
|
WWAV
392
DELISTED
The WhiteWave Foods Company
WWAV
| $20.5M | 0.05% |
364,412
+13,948
| +4% | +$770K |
|
393
Snap-on
SNA
$21.5B
| $20.4M | 0.05% |
121,184
+2,612
| +2% | +$449K |
|
394
Akamai
AKAM
$15.6B
| $20.4M | 0.05% |
342,199
+8,320
| +2% | +$547K |
|
395
Textron
TXT
$14.7B
| $20.4M | 0.05% |
429,274
+14,133
| +3% | +$682K |
|
|
CDK
396
DELISTED
CDK Global, Inc.
CDK
| $20.4M | 0.05% |
313,196
+6,901
| +2% | +$442K |
|
397
Masco
MAS
$14.3B
| $20.3M | 0.05% |
598,479
+3,971
| +0.7% | +$133K |
|
|
VAR
398
DELISTED
Varian Medical Systems, Inc.
VAR
| $20.2M | 0.05% |
221,424
-14,693
| -6% | -$1.23M |
|
399
CBRE Group
CBRE
$43.3B
| $20.1M | 0.05% |
577,087
+16,677
| +3% | +$558K |
|
400
Unum
UNM
$13.2B
| $20.1M | 0.05% |
427,974
+6,932
| +2% | +$325K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.